These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 36979703)
1. The Role of the Ectopeptidase APN/CD13 in Cancer. Lendeckel U; Karimi F; Al Abdulla R; Wolke C Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979703 [TBL] [Abstract][Full Text] [Related]
2. MT95-4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse model. Akita S; Hattori N; Masuda T; Horimasu Y; Nakashima T; Iwamoto H; Fujitaka K; Miyake M; Kohno N Cancer Sci; 2015 Jul; 106(7):921-8. PubMed ID: 25950387 [TBL] [Abstract][Full Text] [Related]
3. The angiogenic regulator CD13/APN is a transcriptional target of Ras signaling pathways in endothelial morphogenesis. Bhagwat SV; Petrovic N; Okamoto Y; Shapiro LH Blood; 2003 Mar; 101(5):1818-26. PubMed ID: 12406907 [TBL] [Abstract][Full Text] [Related]
4. Biological significance of aminopeptidase N/CD13 in thyroid carcinomas. Kehlen A; Lendeckel U; Dralle H; Langner J; Hoang-Vu C Cancer Res; 2003 Dec; 63(23):8500-6. PubMed ID: 14679016 [TBL] [Abstract][Full Text] [Related]
5. Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer. Hashida H; Takabayashi A; Kanai M; Adachi M; Kondo K; Kohno N; Yamaoka Y; Miyake M Gastroenterology; 2002 Feb; 122(2):376-86. PubMed ID: 11832452 [TBL] [Abstract][Full Text] [Related]
6. Kis A; Dénes N; Szabó JP; Arató V; Beke L; Matolay O; Enyedi KN; Méhes G; Mező G; Bai P; Kertész I; Trencsényi G Biomed Res Int; 2021; 2021():6642973. PubMed ID: 33778075 [TBL] [Abstract][Full Text] [Related]
7. Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells. Cui SX; Qu XJ; Gao ZH; Zhang YS; Zhang XF; Zhao CR; Xu WF; Li QB; Han JX Cancer Lett; 2010 Jun; 292(2):153-62. PubMed ID: 20042271 [TBL] [Abstract][Full Text] [Related]
8. In vivo imaging of Aminopeptidase N (CD13) receptors in experimental renal tumors using the novel radiotracer (68)Ga-NOTA-c(NGR). Máté G; Kertész I; Enyedi KN; Mező G; Angyal J; Vasas N; Kis A; Szabó É; Emri M; Bíró T; Galuska L; Trencsényi G Eur J Pharm Sci; 2015 Mar; 69():61-71. PubMed ID: 25592229 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of aminopeptidase N in non-small cell lung cancer. Tokuhara T; Hattori N; Ishida H; Hirai T; Higashiyama M; Kodama K; Miyake M Clin Cancer Res; 2006 Jul; 12(13):3971-8. PubMed ID: 16818694 [TBL] [Abstract][Full Text] [Related]
10. CD13/APN is activated by angiogenic signals and is essential for capillary tube formation. Bhagwat SV; Lahdenranta J; Giordano R; Arap W; Pasqualini R; Shapiro LH Blood; 2001 Feb; 97(3):652-9. PubMed ID: 11157481 [TBL] [Abstract][Full Text] [Related]
11. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Pasqualini R; Koivunen E; Kain R; Lahdenranta J; Sakamoto M; Stryhn A; Ashmun RA; Shapiro LH; Arap W; Ruoslahti E Cancer Res; 2000 Feb; 60(3):722-7. PubMed ID: 10676659 [TBL] [Abstract][Full Text] [Related]
12. CIP-13F, a novel aminopeptidase N (APN/CD13) inhibitor, inhibits Lewis lung carcinoma growth and metastasis in mice. Pei KL; Yuan Y; Qin SH; Wang Y; Zhou L; Zhang HL; Qu XJ; Cui SX Cancer Chemother Pharmacol; 2012 Apr; 69(4):1029-38. PubMed ID: 22186885 [TBL] [Abstract][Full Text] [Related]
13. In vivo assessment of aminopeptidase N (APN/CD13) specificity of different Kis A; Dénes N; Szabó JP; Arató V; Jószai I; Enyedi KN; Lakatos S; Garai I; Mező G; Kertész I; Trencsényi G Int J Pharm; 2020 Nov; 589():119881. PubMed ID: 32946975 [TBL] [Abstract][Full Text] [Related]
14. cNGR: a novel homing sequence for CD13/APN targeted molecular imaging of murine cardiac angiogenesis in vivo. Buehler A; van Zandvoort MA; Stelt BJ; Hackeng TM; Schrans-Stassen BH; Bennaghmouch A; Hofstra L; Cleutjens JP; Duijvestijn A; Smeets MB; de Kleijn DP; Post MJ; de Muinck ED Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2681-7. PubMed ID: 16990557 [TBL] [Abstract][Full Text] [Related]
15. Aminopeptidase N/CD13 as a potential therapeutic target in malignant pleural mesothelioma. Otsuki T; Nakashima T; Hamada H; Takayama Y; Akita S; Masuda T; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Miyata Y; Miyake M; Kohno N; Okada M; Hattori N Eur Respir J; 2018 May; 51(5):. PubMed ID: 29519924 [TBL] [Abstract][Full Text] [Related]
16. Regulation of aminopeptidase N (EC 3.4.11.2; APN; CD13) on the HL-60 cell line by TGF-beta(1). Gabrilovac J; Breljak D; Cupić B Int Immunopharmacol; 2008 May; 8(5):613-23. PubMed ID: 18387503 [TBL] [Abstract][Full Text] [Related]
17. A unified mechanism for aminopeptidase N-based tumor cell motility and tumor-homing therapy. Liu C; Yang Y; Chen L; Lin YL; Li F J Biol Chem; 2014 Dec; 289(50):34520-9. PubMed ID: 25359769 [TBL] [Abstract][Full Text] [Related]
18. Possible contribution of aminopeptidase N (APN/CD13) to migration and invasion of human osteosarcoma cell lines. Liang W; Gao B; Xu G; Weng D; Xie M; Qian Y Int J Oncol; 2014 Dec; 45(6):2475-85. PubMed ID: 25340499 [TBL] [Abstract][Full Text] [Related]
19. Regulation of aminopeptidase N (EC 3.4.11.2; APN; CD13) by interferon-gamma on the HL-60 cell line. Gabrilovac J; Breljak D; Cupić B; Ambriović-Ristov A Life Sci; 2005 Apr; 76(23):2681-97. PubMed ID: 15792835 [TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta increases the expression of aminopeptidase N/CD13 mRNA and protein in monocytes and monocytic cell lines. Kehlen A; Langner J; Riemann D Adv Exp Med Biol; 2000; 477():49-56. PubMed ID: 10849730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]